Financial Toxicity

August 2023 Vol 14, No 8 — August 22, 2023
To set the stage: it had been a successful 7 months of figuring out my new role as an oncology patient financial advocate. Things were clicking, processes and workflows were making sense, and, most importantly, I was helping patients with cancer.

August 2022 Vol 13, No 8 — August 29, 2022
The Disco App, born from “DIScussions of COst” and designed by Dr Hamel and her team, is a novel point-of-care communication intervention aimed at improving discussions of cost between patients and their oncologists, while alleviating financial toxicity in the process.

July 2022 Vol 13, No 7 — July 25, 2022
FDA-approved oral cancer drugs are not cheap, and many patients are unable to afford these promising therapies with extremely high price tags. Depending on the type of cancer and the drug used to treat it, the price of oral cancer therapy can range from about $10,000 to $25,000 per month.

May 2022 Vol 13, No 5 — June 1, 2022
A study of healthcare staff perspectives of financial toxicity experienced by cancer patients and staff- and systems-level cancer care delivery approaches for addressing financial toxicity.

March 2021 Vol 12, No 3 — March 22, 2021
Medical insurance, employment rights, and financial toxicity! Oh my! Where can patients turn when faced with a legal issue related to their diagnosis?

December 2020 Vol 11, No 12 — December 4, 2020
The higher the financial distress experienced by a patient with cancer, the lower their health-related quality of life.

The Affordable Care Act and the Cancer Community
Video Library — November 8, 2020
The Affordable Care Act touches many areas of the cancer community and the healthcare system. Watch Joanna Fawzy Morales, Esq., CEO of Triage Cancer; and Monica Fawzy Bryant, Esq., COO of Triage Cancer, discuss the future of the Affordable Care Act.

Web Exclusives — November 5, 2019
  • Xospata Extends Overall Survival in Patients with FLT3 Mutation–Positive Relapsed or Refractory Acute Myeloid Leukemia
  • Published Results from KEYNOTE-048 Trial Show Extended Survival with Keytruda in Advanced Head and Neck Cancers
  • Discussing Costs of Genomic Testing with Patients

March 2019 Vol 10, No 3 — March 20, 2019
A commentary on the government’s efforts to reduce the price of drugs for patients who have cancer or other chronic illnesses.

September 2017 Vol 8, No 9 — August 31, 2017
At the recent 2017 Annual Meeting of the Multinational Association of Supportive Care in Cancer, Ronan Kelly, MD, Johns Hopkins Medicine International, The Sidney Kimmel Cancer Center, Baltimore, MD, spoke about financial toxicity, the need for value-based care to address it, and what oncologists and healthcare providers can do to reduce costs of cancer care.

August 2017 Vol 8, No 8 — August 3, 2017
Financial toxicity can be long lasting, and the extent to which patients are affected often depends on when in the time of their benefit year they are diagnosed.

May 2016 Vol 7, No 4 — April 29, 2016
Researchers in Chicago have developed a financial toxicity grading system based on independent and clinically meaningful changes in health-related quality of life.

Journal of Oncology Navigation & Survivorship
JONS

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
    Profession or Role
    Primary Specialty or Disease State
    Country